Astrana Health ASTH
$28.90 +$0.22 (+0.77%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.90 0.00%
Open$28.52
Prev close$28.68
Day range$28.33 – $29.75
Volume441.0K
Market cap$1.44B
P/E (TTM)26.8
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.02B+7.1% YoY
Operating profit$39.88M+107.6% YoY
Net profit$20.27M+1,782.0% YoY
Diluted EPS$0.26+2,500.0% YoY
Free cash flow$12.44M+68.0% YoY
Operating cash flow$16.27M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin11.0%
Operating margin3.1%
Net margin1.4%
Return on equity6.5%
Return on assets2.3%
Return on invested capital4.6%
Current ratio1.25
Liabilities / assets73.1%
Cash & investments$396.23M
Total debt$966.77M
Net cash (debt)-$570.54M
Free cash flow / sales2.5%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.02B | $972.52M | $965.10M | $3.18B | $950.53M |
| Total Operating Revenue | $1.02B | $972.52M | $965.10M | $3.18B | $950.53M |
| Cost of Revenue | $900.07M | $868.50M | $859.36M | $2.84B | $855.48M |
| Gross Profit | $123.55M | $104.02M | $105.74M | $341.53M | $95.04M |
| Operating Expense | $83.67M | $69.70M | $77.22M | $263.01M | $76.65M |
| Selling and Admin Expenses | $68.05M | $54.15M | $61.74M | $217.26M | $60.25M |
| -General & Admin Expense | $68.05M | $54.15M | $61.74M | $217.26M | $60.25M |
| Depreciation & Amortization & Depletion | $15.62M | $15.55M | $15.48M | $45.75M | $16.40M |
| -Depreciation & Amortization | $15.62M | $15.55M | $15.48M | $45.75M | $16.40M |
| Operating Profit | $39.88M | $34.32M | $28.53M | $78.53M | $18.40M |
| Net Non-Operating Interest Income (Expense) | -$10.87M | -$10.09M | -$12.29M | -$37.77M | -$13.53M |
| Non-Operating Interest Income | $4.15M | $5.91M | $3.82M | $12.16M | $3.99M |
| Non-Operating Interest Expense | $15.02M | $16.00M | $16.10M | $49.93M | $17.52M |
| Other Income (Expense) | $3.22M | $2.98M | $3.47M | -$1.15M | $2.64M |
| Gain on Sale of Security | $1.13M | $4.73M | $1.08M | -$68,000.00 | $769,000.00 |
| Earnings from Equity Interest | $860,000.00 | $548,000.00 | $1.72M | $1.71M | $1.18M |
| Other Non-Operating Income (Expenses) | $1.23M | -$2.30M | $662,000.00 | -$2.79M | $699,000.00 |
| Pretax Profit | $32.22M | $27.21M | $19.71M | $39.61M | $7.51M |
| Tax | $11.95M | $8.76M | $6.58M | $15.53M | $944,000.00 |
| Net Profit | $20.27M | $18.45M | $13.13M | $24.08M | $6.56M |
| Profit from Continuing Operations | $20.27M | $18.45M | $13.13M | $24.08M | $6.56M |
| Minority Interests | $7.32M | -$1.29M | -$1.31M | $1.59M | $563,000.00 |
| Net Income to Parent Company | $12.95M | $19.74M | $14.44M | $22.49M | $6.00M |
| Net Income to Common Stockholders | $12.95M | $19.74M | $14.44M | $22.49M | $6.00M |
| Basic EPS | $0.26 | $0.40 | $0.30 | $0.46 | $0.12 |
| Diluted EPS | $0.26 | $0.40 | $0.29 | $0.46 | $0.12 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.34B | $2.28B | $2.36B | $2.22B | $2.22B |
| Total Current Assets | $979.97M | $919.16M | $1.00B | $863.31M | $863.31M |
| Cash and Cash Equivalents & Short-Term Investments | $396.23M | $400.79M | $478.38M | $429.47M | $429.47M |
| -Cash and Cash Equivalents | $396.23M | $400.79M | $478.38M | $429.47M | $429.47M |
| Receivables | $554.40M | $492.51M | $500.07M | $407.58M | $407.58M |
| -Accounts Receivable | $530.89M | $465.08M | $467.40M | $374.47M | $374.47M |
| -Loans Receivable | $3.13M | $3.32M | $4.66M | $4.93M | $4.93M |
| -Taxes Receivable | $0.00 | $0.00 | $0.00 | $1.80M | $1.80M |
| -Other Receivables | $20.38M | $24.11M | $28.02M | $26.39M | $26.39M |
| Other Current Assets | $29.35M | $25.86M | $25.65M | $26.26M | $26.26M |
| Total Non-Current Assets | $1.36B | $1.36B | $1.35B | $1.36B | $1.36B |
| Net PPE | $114.41M | $101.76M | $93.48M | $93.07M | $93.07M |
| -Gross PPE | $114.41M | $101.76M | $93.48M | $122.74M | $122.74M |
| Investments and Advances | $27.02M | $27.81M | $27.26M | $28.53M | $28.53M |
| -Long Term Equity Investment | $27.02M | $27.81M | $27.26M | $25.64M | $25.64M |
| Non Current Accounts Receivables | $26.22M | $26.22M | $26.22M | $26.22M | $26.22M |
| Non-Current Note Receivables | $49.37M | $49.27M | $49.07M | $48.72M | $48.72M |
| Goodwill and Other Intangible Assets | $1.12B | $1.13B | $1.13B | $1.14B | $1.14B |
| -Goodwill | $889.39M | $887.00M | $874.80M | $865.31M | $865.31M |
| -Other Intangible Assets | $229.53M | $243.31M | $257.12M | $270.97M | $270.97M |
| Other Non-Current Assets | $27.52M | $27.55M | $26.79M | $22.53M | $22.53M |
| Total Liabilities | $1.71B | $1.68B | $1.78B | $1.66B | $1.66B |
| Total Current Liabilities | $786.07M | $747.64M | $745.37M | $615.27M | $615.27M |
| Payables | $214.04M | $201.06M | $192.44M | $160.53M | $160.53M |
| -Accounts Payable | $51.04M | $46.53M | $54.33M | $44.84M | $44.84M |
| -Total Tax Payable | $2.56M | $2.08M | $2.51M | – | – |
| -Due to Related Parties Current | $10.59M | $8.70M | $9.62M | $8.99M | $8.99M |
| -Other Payable | $149.85M | $143.75M | $125.99M | $106.69M | $106.69M |
| Current Accrued Expenses | $25.12M | $9.49M | $8.55M | $4.64M | $4.64M |
| Short-Term Debt and Capital Lease Obligation | $70.44M | $62.79M | $55.42M | $55.67M | $55.67M |
| -Current Debt | $59.83M | $53.85M | $47.87M | $47.87M | $47.87M |
| -Current Capital Lease Obligation | $10.61M | $8.94M | $7.56M | $7.81M | $7.81M |
| Other Current Liabilities | $436.83M | $433.14M | $462.35M | $360.16M | $360.16M |
| Total Non-Current Liabilities | $925.86M | $935.86M | $1.04B | $1.05B | $1.05B |
| Long Term Debt and Capital Lease Obligation | $906.94M | $916.63M | $1.01B | $1.02B | $1.02B |
| -Long Term Debt | $865.55M | $882.65M | $979.76M | $990.90M | $990.90M |
| -Long Term Capital Lease Obligation | $41.39M | $33.98M | $30.01M | $31.55M | $31.55M |
| Non-Current Deferred Liabilities | $7.64M | $8.80M | $7.40M | $5.49M | $5.49M |
| Other Non-Current Liabilities | $11.29M | $10.44M | $18.83M | $17.11M | $17.11M |
| Total Equity | $631.50M | $598.58M | $577.46M | $558.33M | $558.33M |
| Stockholders' Equity | $856.62M | $830.22M | $800.27M | $779.29M | $779.29M |
| Capital Stock | $49,000.00 | $49,000.00 | $49,000.00 | $49,000.00 | $49,000.00 |
| -Common Stock | $49,000.00 | $49,000.00 | $49,000.00 | $49,000.00 | $49,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | – | – |
| Additional Paid-In Capital | $501.37M | $487.82M | $477.51M | $470.86M | $470.86M |
| Retained Earnings | $355.20M | $342.36M | $322.71M | $308.38M | $308.38M |
| Minority Interests | -$225.12M | -$231.65M | -$222.81M | -$220.96M | -$220.96M |
| -Accumulated Depreciation | – | – | – | -$29.67M | -$29.67M |
| Current Deferred Liabilities | – | – | – | $2.66M | $2.66M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $16.27M | $32.75M | $68.06M | $114.60M | -$2.89M |
| Net cash flow from continuing operations | $16.27M | $32.75M | $68.06M | $114.60M | -$2.89M |
| Net Income from Continuing Operations | $20.27M | $18.45M | $13.13M | $24.08M | $6.56M |
| Depreciation & Depletion & Amortization | $15.62M | $15.55M | $15.48M | $45.75M | $16.40M |
| Deferred Tax | -$960,000.00 | $827,000.00 | $1.91M | -$4.29M | $637,000.00 |
| Other Non-Cash Items | $11.03M | -$8.86M | $3.72M | $13.56M | $5.71M |
| Change in Working Capital | -$37.77M | -$5.00M | $23.92M | -$3.10M | -$39.22M |
| Net cash flow from investing | -$5.80M | -$6.23M | -$2.84M | -$539.00M | -$1.06M |
| Net Cash Flow from Continuing Investing Activities | -$5.80M | -$6.23M | -$2.84M | -$539.00M | -$1.06M |
| Net PPE Purchase and Sale | -$3.83M | -$3.88M | -$4.00M | -$10.11M | -$3.06M |
| Net Business Purchase and Sale | -$3.09M | – | – | -$533.50M | -$51,000.00 |
| Net Other Investing Changes | $1.12M | $1.39M | $1.16M | $4.61M | $2.06M |
| Financing Cash Flow | -$15.03M | -$104.07M | -$15.96M | $569.35M | -$26.34M |
| Net Cash Flow from Continuing Financing Activities | -$15.03M | -$104.07M | -$15.96M | $569.35M | -$26.34M |
| Net Issuance Payments Of Debt | -$11.97M | -$91.97M | -$11.97M | $624.01M | -$11.97M |
| Net Common Stock Issuance | -$1.09M | $100,000.00 | -$2.91M | -$15.43M | -$14.47M |
| Cash Dividends Paid | -$928,000.00 | -$95,000.00 | -$104,000.00 | -$7.89M | -$1.56M |
| Net Other Financing Charges | -$1.05M | -$12.11M | -$983,000.00 | -$31.35M | $1.66M |
| Ending Cash Balance | $401.19M | $405.74M | $483.30M | $434.05M | $434.05M |
| Net Change in Cash | -$4.55M | -$77.55M | $49.25M | $144.94M | -$30.28M |
| Beginning Cash Balance | $405.74M | $483.30M | $434.05M | $289.10M | $464.33M |
| Free Cash Flow | $12.44M | $28.87M | $64.06M | $104.49M | -$5.95M |
| -Change in Other Current Assets | – | – | $23.92M | $3.51M | -$32.62M |
| -Change in Receivables | – | – | – | -$7.16M | – |
| -Change in Prepaid Assets | – | – | – | $4.72M | – |
| -Change in Payables and Accrued Expense | – | – | – | -$11.69M | – |
| -Change in Other Current Liabilities | – | – | – | $2.21M | – |
| -Change In Other Working Capital | – | – | – | $5.33M | – |
No comments yet — be the first to weigh in on ASTH.
Sign in to join the discussion.